Project/Area Number |
12670415
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
内科学一般
|
Research Institution | The University of Tokyo |
Principal Investigator |
ISHII Akira The University of Tokyo, Graduate School of Medicine, Lecturer, 医学部・附属病院, 講師 (30272553)
|
Co-Investigator(Kenkyū-buntansha) |
HIRAI Koichi The University of Tokyo, Graduate School of Medicine, Visiting Associate Professor, 大学院・医学系研究科, 客員助教授 (10156630)
|
Project Period (FY) |
2000 – 2001
|
Project Status |
Completed (Fiscal Year 2001)
|
Budget Amount *help |
¥3,200,000 (Direct Cost: ¥3,200,000)
Fiscal Year 2001: ¥900,000 (Direct Cost: ¥900,000)
Fiscal Year 2000: ¥2,300,000 (Direct Cost: ¥2,300,000)
|
Keywords | bronchial asthma / allergy / Th2 cells / chemokine / TARC / CCL17 / MDC / CCL22 / CCR4 / bronchial epithelial cells / ELISA |
Research Abstract |
We investigated the expression of Th2-specific chemolines, i. e., TARC (thymus and activation regulated chemokine) / CCL 17 and MDC (macrophage-derived chemokine) / CCL22 in bronchial asthma. Bronchial epithelium of asthmatics but not normal exhibited intense immunoreactivity with TARC. MDC immunoreactivty was only weak in both asthmatic and normal epithelium, and no difference of staining intensity was observed in both groups. Bronchial epithelial cell line cells liberated ng/ml quantities of TARC but not MDC in response to combined stimulation with IL-4/TNF-α. (Sekiya. T, et al. J. Immunol.65 : 2205-13, 2000) TARC levels in sputum and serum in asthmatics was increased compared to those in normals. On the other hand, no significant difference was observed in MDC level in both group. (Seliya. T, et al. Allergy, in press)
|